Edit |   |
---|---|
Antigenic Specificity | CD3 + CD19 (Blinatumomab biosimilar) |
Clone | monoclonal |
Host Species | n/a |
Reactive Species | human |
Isotype | n/a |
Format | Protein A/G purified, low endotoxin |
Size | 5mg |
Concentration | 5mg/ml |
Applications | Functional Assays. RUO |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Specificity: detects human CD3/CD19. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Blinatumomab. Blinatumomab is a bispecific T-cell engager (BiTE). It enables a patient's T cells to recognize malignant B cells. A molecule of blinatumomab combines two binding sites: a CD3 site for T cells and a CD19 site for the target B cells. |
Immunogen | n/a |
Other Names | n/a |
Gene, Accession # | n/a |
Catalog # | ICH5025-5mg |
Price | $4000 |
Order / More Info | CD3 + CD19 (Blinatumomab biosimilar) Antibody from ICHORBIO |
Product Specific References | n/a |
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio